BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

52
BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST

Transcript of BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

Page 1: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

BYDR. FATMA AL-QAHTANI

CONSULTANT HAEMATOLOGIST

Page 2: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 3: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 4: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 5: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 6: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 7: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 8: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

1 2

3 4

Blood DonationBlood Donation

Page 9: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

5 6

7 8

Page 10: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

9 10

11 12

Page 11: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 12: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 13: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 14: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 15: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 16: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

Antibody specificities related to the mechanism of immune haemolytic destruction.

Blood group system

Intravascular haemolysis

Extra vascular haemolysis

ABO,HA,B,H

RH All

KellKK, k, Kpa, Kpb, Jsa, Jsb

KiddJkaJka, JKb, Jk3

Duffy Fya, Fyb

MNS M,S,s,U

LutheranLUb

LewisLea

CartwrightYta

ColtonCoa, Cob

DombrockDoa, Dob

Page 17: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

Glycosyltransfereases produced by genes encoding

for antigens within the ABO, H, and Lewis blood group system.

GeneAlleleTransferaseFUT1H

H

α-2-L-fucosyltransferase

None

AAα-3-N-acetyl-D-galactosaminyltransferase

BBα-3-D-galactosyltransferase

OONone

FUT2Se

se

α-2-L-fucosyltransferase

None

FUT3Le

le

α-3/4-L-fucosyltransferase

None

Page 18: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 19: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 20: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 21: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 22: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

ABO blood group system

Blood groupSubgroupAntigens on red cells

Antibodies in plasma

AA1

A2

A + A1

A

Anti-B

(Anti- A1)*

B-BAnti-A, Anti- A1

ABA1B

A2B

A + A1 + B

A + B

None

(Anti- A1)*

O-(H)†Anti-A

Anti- A1

Anti-B

Anti-A,B†

* Anti- A1 found in 1-2% of A2 subjects and 25-30% of A2B subjects.

† The amount of H antigen is influenced by the ABO group; O cells contain most H and A1B cells least. Anit-H may be found in occasional A1 and A1B subject (see text).

† Crossreactivity with both A and B cells.

Page 23: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

The “Front Type" determines which antigens ("flags") in the ABO blood group system are on the patient's Red Blood Cells as follows:

A antigen only Type A B antigen only Type B A and B antigens Type AB Neither A or B Type O

Page 24: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

The “Back Type" identifies the isohaemagglutinin (Naturally Occurring Antibody) in the patient's serum and should correspond to the antigens found on the Red Blood Cells as follows:

Anti-B Type A Anti-A Type B Anti-A and anti-B Type O Neither anti-A or anti-B Type AB

In addition, RBCs are Rh typed and identified as "D“ positive or

negative

Page 25: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

ABO Grouping------------------------------------------ Reactions of

-------------------------------------Cells with Serum

with------------------------------------- Anti-A Anti-B A Cells

B CellsBlood Group (forward grouping) (reverse

grouping)----------------------------------------------- 0 0 0 + + A + 0 0 + B 0 + + 0 AB + + 0 0

Page 26: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 27: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 28: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 29: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 30: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 31: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

The most common Rh phenotypes with possible genotypes and frequencies in an English population (accounting for >99% of all Rh genotypes in this

population)53

Reaction with anti-Phenotype/most probable genotypePossible genotypesFrequency DCcEe

+++-+DCe/dce/R1DCe/dce/R1r

DCe/Dce/R1RO

DCe/dCe/R0r’

32.68

2.16

0.05

++--+DCe/DCe/R1R1DCe/DCe/R1R1

DCe/dCe/R1r’

17.68

0.82

--+-+dce/dce rrdce/dce rr15.10

-++-+Cde/cde r’rCde/cde r’r0.76

--+++cdE/cde r”rcdE/cde r”r0.92

+++++DCe/DcE R1R2DCe/DcE R1R2

DCe/dcE R1 R”

DcE/dCe R2 r’

DCE/cde Rzr

Dce/DCE RoRz

Dce/dCE RoRy

11.87

1.00

0.28

0.19

0.01

<0.01

+-++dCe/DCE R2rDcE/dce R2r

DcE/Dce R2R0

Dce/dcE Ror”

10.97

0.73

0.06

+-+-+Dce/cdeR0r

Dce/Dce R0R0

2.00

0.07

+-++-DcE/DcE R2R2DcE/DcE R2R2

DcE/dcE R2r”

1.99

0.34

Page 32: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

The Rh haplotypes in order of frequency (Fisher nomenclature) in caucasians and the corresponding short notations

FisherShort notations Approximate frequency (%)CDeR1 41

Cder 39

cDER214

cD3 RO3

CwDeR1w1

cdEr”1

Cde r’1

CDE Rz Rare

CdERy Rare

Page 33: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

ABO group and Rh type Screening for blood-group antibodies Serologic test for syphilis Serologic tests for human retroviruses including:

HIV-1 antibodyHIV-2 antibodyHIV p24 antigenHTLV I antibodies

Serologic tests for hepatitis including: Hepatitis B core antibody (HBcAb) Hepatitis B surface antigen (HBsAg) Hepatitis C antibody

Page 34: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

It determines compatibility between patient serum and donor red blood cells.

A full crossmatch procedure takes about 45 minutes to complete and cannot be shortened.

Units are refrigerated until used. A unit of blood MUST be properly labeled and

the label MUST be checked before use.

Page 35: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

PREPARATION

Page 36: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 37: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 38: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 39: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 40: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 41: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 42: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 43: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 44: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 45: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.
Page 46: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

Predeposited: Blood is collected in the weeks prior elective surgery

Haemodilution:Blood is collected immediately before surgery to be reinfused at the end of the operation

Salvage:Heavy blood loss during operation is collected to be reinfused

Page 47: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

Choice of ABO group for blood products for administration to neonates and infants

younger than age 4 monthsInfants ABO Group

ABO group of blood product to be transfused

Red cells Platelets FFP*

OOOO

AA or O†AA or AB

BB or O†B† or A or OB or AB

ABAB or A or B or O†

AB† or AAB

FFP, fresh plasma.

* Only babies and infants who are blood group O should receive group O FFP because of anti-A and anti-B antibodies, whereas group AB FFP contains no naturally occurring antibodies. †Group O products must be checked for high-titre anti-A and anti-B before being given to recipients that are not group O. This is particularly important for platelets because of the relatively large volumes of plasma.

•†Group B or AB platelets may not be available.

Page 48: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

Immediate Transfusion Reactions• Hemolytic Reactions• Allergic Reactions• Febrile Reactions• Transfusion related acute lung injury (TRALI) • Bacterial Contamination• Circulatory Overload • Citrate toxicity• Air embolism• Alloimmunization:

• RBCs• Platelets

Page 49: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

Delayed Transfusion Reactions

• Graft Versus Host Disease (GVHD)• Transfusion-associated graft versus host disease

(TAGVHD)

• Post-transfusion purpura • Haemosiderosis•H.D.N.

Page 50: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

Delayed Transfusion Reactions (Cont…)

Transmitted Diseases Hepatitis B Hepatitis C Human Immunodeficiency Virus (HIV) Human T-lymphocytotrophic Virus (HTLV-1) Cytomegalovirus (CMV) Kaposi’s sarcoma and human herpes virus-8 (KS & HHV-8) Malaria Leishmaniasis Others:

Babesiosis.Lyme disease.Chagas' diseaseCreutzfeldt-Jakob Disease (CJD)Toxoplasmosis

Page 51: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

Evidence of Haemolysis Examine patient’s plasma and urine for haemoglobin and its derivaties.

Blood film may show spherocytosis Evidence of incompatibility

Clerical checks. An identification error will indicate the type incompatibility.

If no evidence of clerical error, proceed as follows: Repeat ABO and Rh D groups of patient and donor unit and

screen for antibodies. Use patient’s pre-and post-transfusion samples Repeat compatibility tests, using patient’s pre-and post -

transfusion serum Direct antiglobulin test on post-transfusion red cells may

indicate antibody and/or complement Evidence of bacterial infection of donor blood

Gram stain and culture donor blood.

Page 52: BY DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST.

THANK YOU